Antimalarial drugs and glucose metabolism

British Journal of Clinical Pharmacology

Volumn 44, Issue 1, 1997, Pages 1-7

  Davis, T M E ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Antimalarial drugs; Glucose; Hypoglycaemia; Insulin

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; CHLOROQUINE; GLUCAGON; GLUCOSE; HALOFANTRINE; INSULIN; INTRALIPID; MEFLOQUINE; POTASSIUM CHANNEL; QUINIDINE; QUININE; SOMATOSTATIN DERIVATIVE;

ARTICLE; CARDIOTOXICITY; COMPUTER MODEL; DRUG MECHANISM; GLUCOSE METABOLISM; HUMAN; HYPOGLYCEMIA; INSULIN RELEASE; INSULIN SENSITIVITY; MALARIA; MALARIA FALCIPARUM; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 0030740855     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1997.00597.x     Document Type: Article

References (45)

1. Warrell DA, Molyneux M, Beaks P. Severe and complicated malaria. Trans R Soc Trop Med Hyg 1990; 84(suppl. 2): 1-69.
2. Phillips RE, Looareesuwan S, White NJ, et al. Hypoglycaemia and antimalarial drugs: quinidine and release of insulin. Br Med J 1986; 292: 1319-1321.
3. Smith GD, Amos TA, Mahler R, Peters TJ. Effect of chloroquine on insulin and glucose homoeostasis in normal subjects and patients with non-insulin-dependent diabetes mellitus. Br Med J 1987; 294: 465-467.
4. Powrie JK, Smith GD, Shojace-Moradie F, Sonksen PH, Jones RH. Mode of action of chloroquine in patients with non-insulin-dependent diabetes mellitus. Am J Physiol 1991; 260: E897-E904.
5. Fisher CSW. Clinical curio: acidosis and hypoglycaemia in malaria. Br Med J 1983; 286: 1261.
6. Davis TME, Dembo LG, Kaye-Eddie SA, Hewitt BJ, Hislop RG, Batty KT. Neurological, cardiovascular and metabolic effects of mefloquine in healthy volunteers: A double-blind, placebo-controlled trial. Br J Clin Pharmacol 1996; 42: 415-421.
7. Best JD, Alford FP, Martin IK, Pestell RG, Ward GM. Practical application of methods for in vivo assessment of insulin secretion and action. Horm Metab Res 1990; 24(suppl.): 60-66.
8. Elahi D. In praise of the hyperglycaemic clamp. A method for assessment of β-cell sensitivity and insulin resistance. Diab Care 1996; 19: 278-286.
9. Bergman RN, Ider YZ, Bowden CR, Cobelli C. Quantitative estimation of insulin sensitivity. Am J Physiol 1979; 236: E667-E677.
10. Pacini G, Bergman RN, MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed 1986; 23: 113-122.
11. Bergman RN. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes 1989; 38: 1512-1527
12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
13. Hosker JP, Matthews DR, Rudenski AS, et al. Continuous infusion of glucose with model assessment: measurement of insulin resistance and beta-cell function in man. Diabetologia 1985; 28: 401-411.
14. Fatherazi S, Cook-DL. Specificity of tetraethylammonium and quinine for three K channels in insulin-secreting cells. J Membr Biol 1991; 120: 105-114.
15. Thevenod F, Chathadi KV, Jiang B, Hopfer U. ATP-sensitive K+ conductance in pancreatic zymogen granules: block by glyburide and activation by diazoxide. J Membr Biol 1992; 129: 253-266.
16. White NJ, Warrell DA, Chanthavanich P, et al. Severe hypoglycemia and hyperinsulinemia in falciparum malaria. N Engl J Med 1983; 309: 61-6.
17. Okitolonda W, Delacollette C, Malengreau M, Henquin JC. High incidence of hypoglycaemia in African patients treated with intravenous quinine for severe malaria. Br Med J 1987; 295: 716-718.
18. Taylor TE, Molyneux ME, Wirima JJ, Fletcher KA, Morris K. Blood glucose levels in Malawian children before and during the administration of intravenous quinine for severe falciparum malaria. N Engl J Med 1988; 319: 1040-1047.
19. Looareesuwan S, Phillips RE, White NJ, et al. Quinine and severe falciparum malaria in late pregnancy. Lancet 1985; ii: 4-8.
20. Seltzer HS. Drug-induced hypoglycemia. A review of 1418 cases. Endocrinol Metab Clin North Am 1989; 18: 163-183.
21. Davis TME, Karbwang J, Looareesuwan S, Turner RC, White NJ. Comparative effects of quinine and quinidine on glucose metabolism in normal man. Br J Clin Pharmacol 1990; 30: 397-403.
22. Hermans M, Coppack S, Levy J. Comparison of 4 in vivo insulin sensitivity tests to discriminate between individuals over the range of glucose tolerance by assessment of their discriminant ratio. Diabetes 1995; 44(suppl 1): 200A.
23. Levy JC, Hammersley MS, Volpicelli G, Barrow B, Turner RC. Glucose tolerance and beta-cell function assessed by Continuous Infusion of Glucose and Oral Glucose Tolerance Test. Diabetologia 1992; 35(suppl 1): A28.
24. Karbwang J, Davis TME, Looareesuwan S, Molunto P, Bunnag D, White NJ. A comparison of the pharmacokinetic and pharmacodynamic properties of quinine and quinidine in healthy Thai males. Br J Clin Pharmacol 1993; 35: 265-271.
25. Davis TME, Pukrittayakamee S, Supanaranond W, et al. Glucose metabolism in quinine-treated patients with uncomplicated falciparum malaria. Clin Endocrinol 1990; 33: 739-749.
26. Pukrittayakamee S, Davis TME, Levy J, et al. The metabolic response to rapid intravenous glucose injection in acute falciparum malaria. Trans R Soc Trop Med Hyg 1991; 85: 189-93.
27. Dyer JR, Davis TME, Giele C, Annus T, Garcia-Webb P, Robson J. The pharmacokinetics and pharmacodynamics of quinine in the diabetic and non-diabetic elderly. Br J Clin Pharmacol 1994; 38: 205-212.
28. Bunnag D, Harinasuta T, Vanijanonta S, et al. Treatment of chloroquine-resistant falciparum malaria with a combination of quinine, quinidine and cinchonine (LA40221) in adults by oral and intravenous administration. Acta Leiden 1987; 55: 139-149.
29. Hien TT, Day NPJ, Phu NH, et al. A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. N Engl J Med 1996; 335: 76-83.
30. Bamber MJ, Redpath A. Chloroquine and hypoglycaemia. Lancet 1987; 316: 1211.
31. White NJ, Miller KD, Churchill FC, et al. Chloroquine treatment of severe malaria in children. Pharmacokinetics, toxicity, and new dosage recommendations. N Engl J Med 1988; 319: 1493-1500.
32. Assan R, Perronne C, Chotard L, Larger E, Vilde JL. Mefloquine-associated hypoglycaemia in a cachectic AIDS patient. Diabete Metab 1995; 21: 54-58.
33. Karbwang J, White NJ. Clinical pharmacokinetics of mefloquine. Clin Pharmacokinet 1990; 19: 264-279.
34. Nosten F, Ter Kuile FO, Luxemberger C, et al. Cardiac effects of antimalarial treatment with halofantrine. Lancet 1993; 341: 1054-1056.
35. Marques JLP, Peacey SR, Harris ND. Effect of hypoglycaemia on the electrocardiogram in patients with NIDDM. Diabetic Med 1996; 13(suppl 3): S35 (abstract).
36. Brewer TG, Peggins JO, Grate SJ, et al. Fatal neurotoxicity of arteether and artemether. Am J Trop Med Hyg 1994; 51: 215-259.
37. Hien TT, White NJ. Qinghaosu. Lancet 1993; 341: 603-608.
38. Batty KT, Davis TME, Thu LTA, Binh TQ, Anh TK, Ilett KF. Selective high performance liquid chromatographic determination of artesunate and α- and β-dihydroartemisinin in patients with falciparum malaria. J Chromatog B 1996; 677: 345-350.
39. Davis TME, Supanaranond W, Pukrittayakamee S, Chanond L, White NJ. Glucose tolerance in pregnant patients with acute falciparum malaria. Trans R Soc Trop Med Hyg 1993; 87: 666-667.
40. Davis TME, Supanaranond W, Pukrittayakamee S, Crawley J, Villaiwanna N, White N. The effect of plasma free fatty acids and long chain triglycerides on glucose metabolism in uncomplicated falciparum malaria. Trans R Soc Trop Med Hyg 1995; 89: 511-515.
41. Davis TME, Looareesuwan S, Pukrittayakamee S, Levy J, Nagachinta B, White N. Glucose turnover in severe falciparum malaria. Metabolism 1993; 42: 334-340.
42. Singh B, Choo KE, Ibrahim J, et al. Non-radioisotopic glucose turnover in Malaysian children with malaria and enteric fever. Proceedings of the XIVth International Congress for Tropical Medicine and Malaria 1996; 199 (abstract).
43. Rehncrona S, Rosen I, Siesjo BK. Excessive cellular acidosis: an important mechanism of neuronal damage in the brain? Acta Physiol Scand 1980; 110: 435-437.
44. Pulsinelli WA, Levy DE, Sigsbee B, Scherer P, Plum F. Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus. Am J Med 1983; 74: 540-544.
45. Phillips RE, Looareesuwan S, Molyneux ME, Hatz C, Warrell DA. Hypoglycaemia and counterregulatory hormone responses in severe falciparum malaria: treatment with Sandostatin. Q J Med 1993; 86: 233-240.